Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2018 Nov 28;9:1385. doi: 10.3389/fphar.2018.01385

Corrigendum: Evaluation of Marbofloxacin in Beagle Dogs After Oral Dosing: Preclinical Safety Evaluation and Comparative Pharmacokinetics of Two Different Tablets

Zhixin Lei 1,2,3, Qianying Liu 1,2,3, Bing Yang 1,2, Haseeb Khaliq 2, Saeed Ahmed 2,3, Bowen Fan 1,2, Jiyue Cao 2,3,*, Qigai He 1,*
PMCID: PMC6280108  PMID: 30542287

In the original article, there was a mistake in Figure 4 as published. Information in Figure 4A was lost, due to a decimal error in the figure axis. The corrected Figure 4 appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Figure 1.

Figure 1

The HPLC method for MBF quantification in plasma. (A) Blank plasma sample, (B) plasma sample at the LLOQ of 0.05 μg/ml, (C) plasma sample after oral administration of Petsen at the point of 16 h, (D) plasma sample after i.v administration of MBF at the point of 16 h. MBF at the peak time of 6.3 min.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES